Clinical Trials Browser

Phase NA × Bevacizumab × Gynecologic × Clear all

NCT06292286 2025-06-11

SCENIC

Phase NA Recruiting

Ovarian Neoplasms

NCT01223235 2018-06-12

Polyvalent Vaccine-KLH Conjugate + Opt-821 Given in Combination With Bevacizumab

Phase NA Completed

22 enrolled 10 charts

Fallopian Tube Neoplasms, Ovarian Neoplasms